Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

GVDs for pharmaceutical companies

Black and white image of man and woman sitting at desk with laptop

Rebrand for Cheshire creative agency, LOVELIVE

Cheshire creative agency LOVELIVE has unveiled a new-look branding; coinciding with the launch of a new website as they celebrate 22% year on year growth and an exciting new focus.

LOVELIVE

- PMLiVE

Fox&Cat Relaunches With An Industry-First Efficiency & Effectiveness Planning Framework, ADAPTTM

F&C network team picture, March 2024 Fox&Cat relaunches today with its new people-first, senior consultant operating model and bespoke planning framework, ADAPTTM. The agency’s lean model...

Fox&Cat

- PMLiVE

Pfizer’s antibiotic combination receives EC approval to treat multidrug-resistant infections

Antimicrobial resistance has been declared by WHO as one of the top ten threats to global health

- PMLiVE

UCB’s Bimzelx granted EC approval to treat hidradenitis suppurativa in adults

The regulator’s decision marks Bimzelx’s fourth approved indication within the EU

- PMLiVE

Takeda’s subcutaneous Entyvio approved by FDA as Crohn’s disease maintenance therapy

Inflammatory bowel disease affects around ten million people worldwide

- PMLiVE

Afon Technology’s glucose monitoring device secures Junkosha award plus $25,000 prize

The company was presented with the award in recognition of its Glucowear device

- PMLiVE

Budget burnout: avoiding the pitfalls of outdated engagement strategies

By Jake Crute

- PMLiVE

Fox&Cat relaunches with industry-first efficiency and effectiveness planning framework ADAPT

ADAPT was created alongside in-house teams, a behaviour change expert and a well-being coach

- PMLiVE

Navigating the future of AI: Insights from EphMRA’s one day meeting in London

Authored by: Ellie Forde and Mark Braund, Directors

Research Partnership

- PMLiVE

Ipsen and Skyhawk announce $1.8bn partnership to advance rare neurological disease therapies

The agreement gives Ipsen an option to receive exclusive global rights to two candidates

- PMLiVE

NICE recommends Menarini’s Nexpovio combination to treat multiple myeloma

More than 4,500 new patients are diagnosed with this form of blood cancer every year in the UK

- PMLiVE

World Health Organization prequalifies simplified oral cholera vaccine Euvichol-S

The acute diarrhoeal illness was reported to affect around 473,000 people in 2022

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links